Involvement of neurokinin 1 and 2 receptors in viscerosensitive response to rectal distension in rats

Gastroenterology
V JuliaL Buéno

Abstract

Tachykinins participate in somatic pain and intestinal motility control. The role of tachykinin receptors in both colonic motor disturbances and visceral pain (abdominal contractions as an index of visceral pain) induced by rectal distension were investigated. Rats were surgically prepared with electrodes implanted on the proximal colon and the abdominal striated muscles. Catheters were implanted in lateral ventricles of the brain. Rectal distension was performed by inflation of a balloon (0.1-1.6 mL) rectally inserted. CP-96,345 and RP-67,580 (neurokinin [NK] 1 antagonists) and SR-48,968 (NK2 antagonist) were injected intraperitoneally (IP) or intracerebroventricularly (ICV) 20 minutes before distension. GR-73,632 and GR-64,639 (NK1, NK2 agonists) were infused intravenously at 0.15 micrograms.kg-1.min-1. Rectal distension evoked a significant inhibition of colonic motility and an increase in abdominal contractions. CP-96,345 injected ICV (0.2-0.8 mg/kg) or IP (5-10 mg/kg) and RP-67,580 (0.2 mg/kg IP) eliminated distension-induced colonic inhibition but did not affect abdominal response. SR-48,968 did not affect colonic response but significantly reduced visceral pain (0.4, 0.8 mg/kg ICV: 5-10 mg/kg IP). GR-73,632 enhanced the ...Continue Reading

Citations

Mar 19, 2003·Alimentary Pharmacology & Therapeutics·H Mertz
Apr 1, 2003·Expert Opinion on Investigational Drugs·Driss Berrada, Tony Lembo
Mar 24, 2004·British Journal of Pharmacology·Alessandro LecciCarlo Alberto Maggi
Jan 10, 2006·American Journal of Physiology. Gastrointestinal and Liver Physiology·Elizabeth C WickKimberly S Kirkwood
Jun 20, 2015·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M CorsettiJ Tack
Feb 13, 2001·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M ToulouseL Buéno
Mar 2, 1999·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·P G McLeanL Buéno
Sep 14, 2004·Journal of Neurobiology·Fernando Cervero, Jennifer M A Laird
Jul 9, 2003·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M LarssonA Bayati
Nov 26, 2009·Therapeutic Advances in Gastroenterology·Alexandru GamanBraden Kuo
Jan 5, 2002·Expert Opinion on Investigational Drugs·A FarhadiA Keshavarzian
Feb 29, 2000·British Journal of Pharmacology·M ToulouseL Buéno
Mar 31, 2005·Journal of Clinical Gastroenterology·Silvia Delgado-Aros, Michael Camilleri
Apr 17, 2004·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·A D ShaftonJ B Furness
Jan 20, 2006·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M H LarssonE Lindström
Oct 21, 1999·The Journal of Pharmacy and Pharmacology·J GoldhillN Selve
Jul 5, 2001·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J M GschossmannE A Mayer
Jul 9, 2003·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J FioramontiL Bueno
Sep 16, 2006·American Journal of Physiology. Gastrointestinal and Liver Physiology·Ching-Liang LuShou-Dong Lee
Sep 14, 2018·Current Medicinal Chemistry·Charlene Gadais, Steven Ballet
Apr 28, 2005·Journal of Gastroenterology and Hepatology·Alicia S Smith, Scott D Smid
Jan 29, 2003·Anesthesiology·Louis P Vera-PortocarreroKarin N Westlund
Nov 8, 2001·European Journal of Pharmacology·R Patacchini, C A Maggi
Mar 29, 2001·European Journal of Pharmacology·R PatacchiniC A Maggi
Jan 1, 1997·Pharmacology & Therapeutics·P Holzer, U Holzer-Petsche
Oct 26, 2000·Neuropeptides·A LecciC A Maggi
Oct 16, 2020·Fundamental & Clinical Pharmacology·Artur UmerRoman P Korolkiewicz
Aug 7, 2021·Autonomic Neuroscience : Basic & Clinical·Hyun Jin Jung, Ronny Priefer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.